نتایج جستجو برای: chb

تعداد نتایج: 1853  

Journal: :Water 2023

Glyphosate is an herbicide that usually used by farmers and considered harmful to the environment in excess amounts. To address these issues, coffee-husk-biochar-loaded Fe3O4 (CHB- Fe3O4) was as adsorbent remove glyphosate from water. CHB-Fe3O4 characteristics such pHpzc, FTIR, SEM were measured understand properties of this adsorbent. The best conditions for removal obtained at pH 2.0, where a...

Journal: :PharmacoEconomics 2011
Helen Dakin Morris Sherman Scott Fung Carrie Fidler Anthony Bentley

INTRODUCTION Previous research has demonstrated that tenofovir disoproxil fumarate (DF) is the most cost-effective nucleos(t)ide treatment for chronic hepatitis B (CHB) in the UK, Spain, Italy and France. However, to our knowledge, no published studies have yet evaluated the cost effectiveness of any treatments for CHB in a Canadian setting, where relative prices and management of CHB differ fr...

Journal: :Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2012
Carla S Coffin Scott K Fung Mang M Ma

Chronic hepatitis B (CHB) is a dynamic disease that is influenced by host and virological factors. The management of CHB has become more complex with the increasing use of long-term oral nucleos⁄tide analogue antiviral therapies and the availability of novel diagnostic assays. Furthermore, there is often a lack of robust data to guide optimal management such as the selection of therapy, duratio...

Journal: :International Journal of Medical Sciences 2005
Ke-Qin Hu

Chronic hepatitis B (CHB) is one of the important public health problems worldwide. Major advances have been made in the treatment of CHB during the past several years. This article systemically reviews advances in the application of HBV DNA quantitation and three approved drugs for HBV treatment, and presents an updated and practical clinical approach to managing CHB. Highly sensitive PCR-base...

2015
Diego J. S. Dias Graziella A. Joanitti Ricardo B. Azevedo Luciano P. Silva Claure N. Lunardi Anderson J. Gomes

The present work aimed to develop and evaluate a colloidal system composed of poly (DL-lactideco-glycolide) (PLGA) nanoparticles (NPs) associated with chlorambucil (CHB) and its effects on cancer cells. The nanoparticles showed %EE (>92%), a mean particle size in the range of 240 to 334 nm and zeta potential of −16.7 to −26.0 mV. In vitro release profile showed a biphasic pattern, with an initi...

2012
P. Surendra Babu

This paper presents an investigation of five-Level Cascaded H – bridge (CHB) Inverter as Distribution Static Compensator (DSTATCOM) in Power System (PS) for compensation of reactive power and harmonics. The advantages of CHB inverter are low harmonic distortion, reduced number of switches and suppression of switching losses. The DSTATCOM helps to improve the power factor and eliminate the Total...

2015
Zhe Chen Xiao Ma Yanling Zhao Jiabo Wang Yaming Zhang Yun Zhu Lifu Wang Chang Chen Shizhang Wei Zhirui Yang Man Gong Honghui Shen Zhaofang Bai Yuming Guo Ming Niu Xiaohe Xiao

Objective. To evaluate the efficacy and safety of Kushenin (KS) combined with nucleoside analogues (NAs) for chronic hepatitis B (CHB). Methods. Randomized controlled trials (RCTs) of KS combined with NAs for CHB were identified through 7 databases. Frequencies of loss of serum HBeAg, HBeAg seroconversion, undetectable serum HBV-DNA, ALT normalization, and adverse events at 48 weeks were abstra...

Journal: :Journal of gastroenterology and hepatology 2008
Laurence Lacey Rong-Nan Chien Wan-Long Chuang Raoh-Fang Pwu

BACKGROUND AND AIMS Chronic hepatitis B (CHB) and its sequelae are major health problems in Taiwan. The purpose of the present study was the economic evaluation of short-duration treatments of CHB and longer duration antiviral treatment for up to 5 years. METHODS Ten-health state CHB disease progression Markov models were used for hepatitis B e antigen (HBeAg)-positive and HBeAg-negative CHB ...

Journal: :Antiviral therapy 2014
Patrick Marcellin Victoria Arama Hakan Leblebicioglu Jean Pierre Zarski Stefan Zeuzem Stefan Mauss Jerzy Sieklucki Monica Acalovschi Gaye Usluer Isabelle Klauck Edith Morais Stefan Bjork Benedicte Lescrauwaet Driss Kamar Krzysztof Simon

BACKGROUND Chronic hepatitis B (CHB) is an important health concern, but there are few studies describing its management in different countries. This prospective, longitudinal, non-interventional study aimed to assess differences in CHB management in five European countries (Germany, France, Poland, Romania and Turkey). METHODS Data were collected from CHB patients' records between 2008 and 2...

2016
Zehra Karacaer Banu Cakir Hakan Erdem Kenan Ugurlu Gul Durmus Nevin Koc Ince Cinar Ozturk Rodrigo Hasbun Ayse Batirel Esmeray Mutlu Yilmaz Ilkay Bozkurt Mustafa Sunbul Aynur Aynioglu Aynur Atilla Ayse Erbay Ayse Inci Cigdem Kader Elif Tukenmez Tigen Gokhan Karaahmetoglu Seher Ayten Coskuner Ebru Dik Huseyin Tarakci Selma Tosun Fatime Korkmaz Servet Kolgelier Fatma Yilmaz Karadag Serpil Erol Kamuran Turker Ceyda Necan Ahmet Melih Sahin Pinar Ergen Gulsen Iskender Pinar Korkmaz Esma Gulesen Eroglu Yasemin Durdu Mehmet Ulug Suna Secil Deniz Filiz Koc Saygın Nayman Alpat Nefise Oztoprak Omer Evirgen Hamdi Sozen Mustafa Dogan Selcuk Kaya Safak Kaya Mustafa Altindis Emel Aslan Recep Tekin Busra Ergut Sezer Kevser Ozdemir Gulden Ersoz Ahmet Sahin Ilhami Celik Emsal Aydin Aliye Bastug Rezan Harman Hacer Deniz Ozkaya Emine Parlak Ilknur Yavuz Suzan Sacar Senol Comoglu Ercan Yenilmez Fatma Sirmatel Ilker Inanc Balkan Yesim Alpay Mustafa Hatipoglu Affan Denk Gunes Senol Mehmet Bitirgen Mehmet Faruk Geyik Rahmet Guner Ayten Kadanali Ahmet Karakas Mustafa Namiduru Hatice Udurgucu Rukiye Pinar Boluktas Ergenekon Karagoz Necati Ormeci

BACKGROUND The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. METHODS This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید